THE ATHENA BREAST HEALTH NETWORK adopted the Health Level Seven International-approved guide for sharing electronic data for breast cancer treatment. The guide was developed by the American Society for Clinical Oncology and approved through HL7 to become a national data standard.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
